- Home
- MKZR vs INBS Comparison
MKZR vs INBS Comparison
Compare MKZR & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MKZR
- INBS
- Stock Information
- Founded
- MKZR 2012
- INBS 2016
- Country
- MKZR United States
- INBS United States
- Employees
- MKZR N/A
- INBS N/A
- Industry
- MKZR
- INBS Medical Specialities
- Sector
- MKZR
- INBS Health Care
- Exchange
- MKZR Nasdaq
- INBS Nasdaq
- Market Cap
- MKZR 10.3M
- INBS 11.7M
- IPO Year
- MKZR N/A
- INBS N/A
- Fundamental
- Price
- MKZR $4.85
- INBS $1.47
- Analyst Decision
- MKZR
- INBS
- Analyst Count
- MKZR 0
- INBS 0
- Target Price
- MKZR N/A
- INBS N/A
- AVG Volume (30 Days)
- MKZR 116.6K
- INBS 188.5K
- Earning Date
- MKZR 08-26-2025
- INBS 08-15-2025
- Dividend Yield
- MKZR 46.39%
- INBS N/A
- EPS Growth
- MKZR N/A
- INBS N/A
- EPS
- MKZR N/A
- INBS N/A
- Revenue
- MKZR $23,037,348.00
- INBS $3,052,532.00
- Revenue This Year
- MKZR N/A
- INBS $280.88
- Revenue Next Year
- MKZR N/A
- INBS $126.26
- P/E Ratio
- MKZR N/A
- INBS N/A
- Revenue Growth
- MKZR 52.64
- INBS N/A
- 52 Week Low
- MKZR $3.89
- INBS $1.00
- 52 Week High
- MKZR $55.00
- INBS $3.00
- Technical
- Relative Strength Index (RSI)
- MKZR N/A
- INBS 41.02
- Support Level
- MKZR N/A
- INBS $1.42
- Resistance Level
- MKZR N/A
- INBS $1.53
- Average True Range (ATR)
- MKZR 0.00
- INBS 0.09
- MACD
- MKZR 0.00
- INBS -0.01
- Stochastic Oscillator
- MKZR 0.00
- INBS 25.00
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).